Board of Directors
The Lundquist Institute Board of Directors plays a pivotal role in guiding the Institute’s strategic direction, ensuring fiscal responsibility, and fostering a culture of excellence.
Mitchel Sayare, PhD | Chair
Chairman, Altimmune Inc.
Delphine Lee, MD, PhD* | Secretary
Chief of Dermatology and Residency Program Director, Harbor-UCLA Medical Center
Eric Daar, MD* | Vice Chair
Chief, Division of HIV Medicine, Harbor-UCLA Medical Center
Tom Anastassiou | Treasurer
Managing Member, Paseo Capital Management LLC
Joseph Berenato
Former Chairman and CEO, Ducommun Inc.
Kelly Callahan, MD*
Chair, Department of Pediatrics, Harbor-UCLA Medical Center
Christian de Virgilio, MD*
Chair, Department of Surgery, Harbor-UCLA Medical Center
Griselda Gutierrez, MD
Chief Medical Officer, Harbor-UCLA Medical Center
Elliot Hinds
Partner, Sheppard Mullin
Christopher Lee, MD
Vice President of Pharmaceuticals and Biotechnology, Capital Group
Melanie Lundquist
Philanthropist
Richard Lundquist
President and CEO, Continental Development Corporation
Paul Mathews, PhD*
Director, Neurotherapeutics at The Lundquist Institute
Loren Miller, MD, MPH*
Associate Chief, Division of Infectious Diseases, Department of Medicine, Harbor-UCLA Medical Center
Steven A. Nissen
President and CEO, Hollywood Chamber of Commerce
Joe W. Ramos, PhD
President and CEO, The Lundquist Institute
Harry B. Rossiter, PhD*
Chair, Research Committee and Director, Respiratory Medicine and Exercise Physiology, The Lundquist Institute
Laura Survant
Partner, Deloitte & Touche LLP
Joseph Thomas, MD*
Chair, Department of Medicine, Harbor-UCLA Medical Center
*Principal Investigator, The Lundquist Institute